SCHEMBL6168637

SCHEMBL6168637

[CH2]Oc1ccc(C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.60
CA2 P00918 3/20 0.60
TSHR P16473 3/20 0.60
TP53 P04637 1/20 0.60
PARP15 Q460N3 1/20 0.54
PARP10 Q53GL7 1/20 0.54
KMT2A Q03164 1/20 0.54
SRD5A2 P31213 3/20 0.52
PKM P14618 1/20 0.52
CA12 O43570 1/20 0.50
CA3 P07451 1/20 0.50
TYR P14679 1/20 0.50
DRD1 P21728 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746609 0.79 TSHR (0.67) CA1CA2TSHRTP53PARP15
Terephthalic Acid SCHEMBL9861713 0.79 PARP10 (0.78) CA1CA2TSHRTP53PARP15
SCHEMBL766069 0.79 PARP10 (0.78) CA1CA2TSHRTP53PARP15
SCHEMBL5581520 0.79 PARP10 (0.78) CA1CA2TSHRTP53PARP15
SCHEMBL22281 0.79 PARP10 (0.78) CA1CA2TSHRTP53PARP15
SCHEMBL7138100 0.78 PARP10 (0.67) CA1CA2PARP15PARP10KMT2A
SCHEMBL2094120 0.78 MAPT (0.67) KMT2AALDH1A1L3MBTL1SMN1; SMN2LMNA
Terephthalic Acid SCHEMBL210852 0.78 TSHR (0.86) CA1CA2TSHRTP53SRD5A2
Terephthalic Acid SCHEMBL1194495 0.78 TSHR (0.86) CA1CA2TSHRTP53SRD5A2
Terephthalic Acid SCHEMBL17628648 0.78 TSHR (0.86) CA1CA2TSHRTP53SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP claimed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP claimed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP claimed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO claimed
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-1144365-B1 INHIBITORS OF ALPHA-4 BETA-1 MEDIATED CELL ADHESION TANABE SEIYAKU CO (JP) 2004-03-17 EP disclosed
EP-1144365-A3 INHIBITORS OF ALPHA-4 BETA-1 MEDIATED CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 2003-07-09 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
EP-1144365-A2 INHIBITORS OF ALPHA-4 BETA-1 MEDIATED CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 2001-10-17 EP disclosed
WO-2000037429-A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 2000-06-29 WO disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
CN-1169441-A Aromatic polycarbodiimide and sheet using it NITTO DENKO CORP (JP) 1998-01-07 CN disclosed
US-4324890-A ANTIBIOTICS, BACTERICIDES MERCK & CO., INC. (US) 1982-04-13 US disclosed
US-4297488-A 7-α-Methoxy cephalosporins MERCK & CO., INC. (US) 1981-10-27 US disclosed
US-4255423-A BACTERICIDES MERCK & CO., INC. (US) 1981-03-10 US disclosed
US-4154845-A ANTIBIOTIC, BACTERICIDE MERCK & CO., INC. (US) 1979-05-15 US disclosed
US-4086423-A CEPHALOSPORINS, CYCLOADDITION OF GLYCINE DERIVATIVE TO THIAZINE COMPOUND MERCK & CO., INC. (US) 1978-04-25 US disclosed
US-4071529-A Derivatives of 6-aminopenicillanic acid MERCK & CO., INC. (US) 1978-01-31 US disclosed
US-4064344-A ANTIBIOTIC MERCK & CO., INC. (US) 1977-12-20 US disclosed
US-3974151-A Cephalosporin compounds MERCK & CO., INC. (US) 1976-08-10 US disclosed